Literature DB >> 17848654

Management of intractable nausea and vomiting in patients at the end of life: "I was feeling nauseous all of the time . . . nothing was working".

Gordon J Wood1, Joseph W Shega, Beth Lynch, Jamie H Von Roenn.   

Abstract

Nausea and vomiting, symptoms that occur commonly near the end of life, represent a substantial source of physical and psychological distress for patients and families. In the context of the case of Mr Q, a 50-year-old man with metastatic esophageal cancer admitted to the hospital with intractable nausea and vomiting, we review the evaluation and treatment of this symptom complex. A thorough history and physical examination are essential first steps in the management of these patients because they define the severity of the symptoms and clues to their underlying etiology. Once the most likely cause is determined, the clinician discerns the mechanism, specific transmitters, and receptors by which this etiology is triggering nausea and vomiting. Subsequent pharmacological management focuses on prescribing the appropriate antagonist to the implicated receptors. If symptoms are refractory despite adequate dosage and around-the-clock prophylactic administration, an empirical trial combining several therapies to block multiple emetic pathways should be attempted. Less traditional agents are also discussed, although evidence for their use is limited. Often, oral administration of medication is not feasible and alternate routes such as rectal suppositories, subcutaneous infusions, and orally dissolvable tablets should be considered. Using this step-wise approach, nausea and vomiting can be successfully managed in most patients at the end of life.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17848654     DOI: 10.1001/jama.298.10.1196

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  17 in total

1.  Clinical pearls in palliative medicine 2012.

Authors:  Keith M Swetz; Elise C Carey; John B Bundrick
Journal:  Mayo Clin Proc       Date:  2012-11       Impact factor: 7.616

Review 2.  Nutrition therapy issues in esophageal cancer.

Authors:  Keith R Miller; Matthew C Bozeman
Journal:  Curr Gastroenterol Rep       Date:  2012-08

3.  A case of pancreatic cancer with severe vomiting treated by endoscopic ultrasound-guided celiac ganglia neurolysis.

Authors:  Asami Kawai; Masataka Kikuyama; Kohei Enokida; Shinya Kawaguchi; Naofumi Shirane; Shuzo Terada
Journal:  Clin J Gastroenterol       Date:  2017-08-16

Review 4.  Hospice in heart failure: why, when, and what then?

Authors:  Jeffrey L Spiess
Journal:  Heart Fail Rev       Date:  2017-09       Impact factor: 4.214

5.  Treating an oft-unrecognized and troublesome entity: using gastric electrical stimulation to reduce symptoms of malignancy-associated gastroparesis.

Authors:  Hamza Shah; Gregg Wendorf; Shifat Ahmed; Lindsay McElmurray; Chris Lahr; Michael Hughes; Brian Beauerle; Ed Miller; Abigail Stocker; Thomas L Abell
Journal:  Support Care Cancer       Date:  2016-08-17       Impact factor: 3.603

6.  Medical complications of bulimia nervosa and their treatments.

Authors:  Katherine Sachs; Philip S Mehler
Journal:  Eat Weight Disord       Date:  2015-07-14       Impact factor: 4.652

Review 7.  Chemotherapy-induced nausea and vomiting: optimizing prevention and management.

Authors:  Kamakshi V Rao; Aimee Faso
Journal:  Am Health Drug Benefits       Date:  2012-07

Review 8.  Treatment of nausea and vomiting in terminally ill cancer patients.

Authors:  Paul A Glare; David Dunwoodie; Katherine Clark; Alicia Ward; Patsy Yates; Sharon Ryan; Janet R Hardy
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  Undertreatment of nausea and other symptoms in hospitalized cancer patients.

Authors:  Judi Greaves; Paul Glare; Linda J Kristjanson; Martin Stockler; Martin H N Tattersall
Journal:  Support Care Cancer       Date:  2008-10-18       Impact factor: 3.603

10.  Palliative care in the emergency department.

Authors:  Susanne M Mierendorf; Vinita Gidvani
Journal:  Perm J       Date:  2014-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.